Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis.
about
Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trial.Pharmacogenetics of efavirenz discontinuation for reported central nervous system symptoms appears to differ by race.CYP2B6 genotypes and early efavirenz-based HIV treatment outcomes in Botswana.Evaluation of universal versus genotype-guided efavirenz dose reduction in pregnant women using population pharmacokinetic modelling.Variation in CYP2A6 Activity and Personalized Medicine.
P2860
Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Investigation of Efavirenz Dis ...... dividuals by Genetic Analysis.
@ast
Investigation of Efavirenz Dis ...... dividuals by Genetic Analysis.
@en
type
label
Investigation of Efavirenz Dis ...... dividuals by Genetic Analysis.
@ast
Investigation of Efavirenz Dis ...... dividuals by Genetic Analysis.
@en
prefLabel
Investigation of Efavirenz Dis ...... dividuals by Genetic Analysis.
@ast
Investigation of Efavirenz Dis ...... dividuals by Genetic Analysis.
@en
P2093
P2860
P50
P1433
P1476
Investigation of Efavirenz Dis ...... dividuals by Genetic Analysis.
@en
P2093
Amalio Telenti
Andrew D Badley
Christoph Wyen
Daniel J Skiest
INSIGHT Study Group
Jacqueline Neuhaus
James Neaton
Margalida Rotger
Nathan W Cummins
P2860
P304
P356
10.1016/J.EBIOM.2015.05.012
P577
2015-05-12T00:00:00Z